Longitudinal study of the ageing trends in QT interval and dispersion in healthy elderly subjects.

636 10. Silwer L, Lundborg CS. Patterns of drug use during a 15 year period: data from a Swedish county, 1988–2002. Pharmacoepidemiol Drug Saf 2005; 14: 813–20. 11. van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A. Estimation of incidence and prevalence of Parkinson’s disease in the elderly using pharmacy records. Pharmacoepidemiol Drug Saf 2001; 10: 549–54. 12. WHO (World Health Organization). Anatomical therapeutics chemical (ATC) classification index with defined daily doses (DDDs). Geneva: WHO, 2001. 13. National cancer registry Ireland. Cancer in Ireland 1994–2001. http://www.ncri.ie (2005) (3 March 2006, date last accessed). 14. Adamson J, Lawlor DA, Ebrahim S. Chronic diseases, locomotor activity limitation and social participation in older women: cross sectional survey of British Women’s Heart and Health Study. Age Ageing 2004; 33: 293–8. 15. Ayis S, Gooberman-Hill R, Ebrahim S. Long-standing and limiting long-standing illness in older people: associations with chronic diseases, psychosocial and environmental factors. Age Ageing 2003; 32: 265–72. 16. National Office Statistics. Health Expectancy Living Longer, More Years in Poor Health. http://www.statistic.gov.uk (2004) (29 January 2006, date last accessed). 17. Perenboom RJ, Van Herten LM, Boshuizen HC, Van Den Bos GA. Trends in disability-free life expectancy. Disabil Rehabil 2004; 26: 377–86. 18. EHEMU. Health Expectancy in Ireland. http://www. hs.le.ac.uk/reves/ehemutest (2005) (22 October 2005, date last accessed). 19. Rector TS, Wickstrom SL, Shah M et al. Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions. Health Serv Res 2004; 39: 1839–57.